Kolexia
Laboure Gaelle
Hématologie
Centre Hospitalier Libourne
Libourne, France
57 Activités
90 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Leucémies Lymphome de Burkitt Leucémie aigüe myéloïde Infections à VIH Lymphome folliculaire Lymphome à cellules du manteau

Industries

Janssen
34 collaboration(s)
Dernière en 2023
Abbvie
24 collaboration(s)
Dernière en 2023
Novartis
11 collaboration(s)
Dernière en 2023
AstraZeneca
9 collaboration(s)
Dernière en 2023

Dernières activités

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood advances   24 octobre 2023
Sexoblogue - J'ai eu l'immense plaisir de travailler en... - Facebook
Facebook   21 juin 2023
Quality of life and response shift effect of diffuse large B-cell lymphoma French patients included in prospective real-life REALYSA cohort in the first year after diagnosis
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group
Annual Meeting Abstracts 2022   15 novembre 2022
REALYSA: REAL WORLD DATA IN LYMPHOMA AND SURVIVAL IN ADULTS
Essai Clinique (Hospices Civils de Lyon)   25 juin 2021
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.
BMC public health   02 mars 2021
Impact de la formation des prescripteurs sur le bon usage des fluoroquinolones dans un centre hospitalier général
21es Journées Nationales d’Infectiologie   01 septembre 2020
OUTCOME OF PATIENTS WITH C-MYC REARRANGED DIFFUSE LARGE B CELL LYMPHOMA ASSOCIATED OR NOT WITH BCL2 AND/OR BCL6 REARRANGEMENT: A MULTICENTRIC AND RETROSPECTIVE STUDY
15th International Conference on Malignant Lymphoma Palazzo dei Congressi, Lugano, Switzerland, 18–22 June, 2019   12 juin 2019
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma.
Blood advances   19 février 2019
Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.
Leukemia   27 janvier 2017